Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 105 articles: HTML format

Single Articles

July 2025
1. SAMSON P, Robinson C
   How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung Cancer Radiation Therapy.
   Int J Radiat Oncol Biol Phys. 2025;122:785.
   PubMed    
   
   
   
2. MEYER S, Hu YC, Rimner A, Mechalakos J, et al
   Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for Adaptive Radiation Therapy.
   Int J Radiat Oncol Biol Phys. 2025;122:818-826.
   PubMed     Abstract available
   
   
   
3. CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al
   Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
   Int J Radiat Oncol Biol Phys. 2025;122:957-967.
   PubMed     Abstract available
   
   
   
4. AKDEMIR EY, Herrera R, Gurdikyan S, Hodgson LC, et al
   Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm.
   Int J Radiat Oncol Biol Phys. 2025;122:739-751.
   PubMed     Abstract available
   
   
   
5. ZHOU L, Sun J, Xie C, Kang K, et al
   Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH).
   Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508.
   PubMed     Abstract available
   
   
   June 2025
6. ZHANG SC, Kehayias CE, Guthier C, He J, et al
   Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
   Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493.
   PubMed     Abstract available
   
   
   
7. ZHANG Y, Laine AM, Iyengar P, Westover KD, et al
   Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.
   Int J Radiat Oncol Biol Phys. 2025;122:374-382.
   PubMed     Abstract available
   
   
   
8. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
   Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).
   Int J Radiat Oncol Biol Phys. 2025;122:365-373.
   PubMed     Abstract available
   
   
   May 2025
9. KEANE F, Daly M, Louie A, Harris J, et al
   Resistance is Futile: Stereotactic Body Radiation Therapy for Oligoprogressive Non-small Cell Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2025;122:1-4.
   PubMed    
   
   
   April 2025
10. ALFAIFI SA, Louie AV, Siva S, Guckenberger M, et al
    International Patterns of Practice for Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of practice for SABR for early-stage NSCLC.
    Int J Radiat Oncol Biol Phys. 2025 Apr 29:S0360-3016(25)00390.
    PubMed     Abstract available
    
    
    
11. SIMONE CB 2ND, Amini A, Chetty IJ, Choi JI, et al
    American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer Executive Summary.
    Int J Radiat Oncol Biol Phys. 2025 Apr 2:S0360-3016(25)00259.
    PubMed     Abstract available
    
    
    
12. PAN S, Chang CW, Tian Z, Wang T, et al
    Data-Driven Volumetric Computed Tomography Image Generation From Surface Structures Using a Patient-Specific Deep Leaning Model.
    Int J Radiat Oncol Biol Phys. 2025;121:1349-1360.
    PubMed     Abstract available
    
    
    
13. HUANG YH, Li Z, Xiong T, Chen Z, et al
    Constructing Surrogate Lung Ventilation Maps From 4-Dimensional Computed Tomography-Derived Subregional Respiratory Dynamics.
    Int J Radiat Oncol Biol Phys. 2025;121:1328-1338.
    PubMed     Abstract available
    
    
    March 2025
14. COOKE SA, Belderbos JSA, Stam B, Reymen B, et al
    Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 28:S0360-3016(25)00228.
    PubMed     Abstract available
    
    
    
15. MONTALVO SK, Lue B, Kakadiaris E, Ahn C, et al
    Global Longitudinal Strain: A Potential Non-invasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Lung Cancer Patients Receiving Thoracic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025 Mar 27:S0360-3016(25)00257.
    PubMed     Abstract available
    
    
    
16. CHEN X, Meng F, Zhang P, Wang L, et al
    Establishing a deep learning model that integrates pre- and mid-treatment computed tomography to predict treatment response for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00243.
    PubMed     Abstract available
    
    
    
17. ALLEN SG, Schonewolf CA, Schipper MJ, Yin HM, et al
    Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality Collaborative.
    Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00236.
    PubMed     Abstract available
    
    
    
18. RIMNER A, Dejonckheere CS, Sahlmann J, Barth SA, et al
    Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 5:S0360-3016(25)00196.
    PubMed     Abstract available
    
    
    
19. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    PubMed     Abstract available
    
    
    February 2025
20. XIAO L, Li Y, Wang S, Fan L, et al
    Early prediction of radiation pneumonitis in patients with lung cancer treated with immunotherapy through monitoring of plasma chemokines.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00151.
    PubMed     Abstract available
    
    
    
21. GAETA B, Eichholz JE, Walch H, Ilica AT, et al
    Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with SRS.
    Int J Radiat Oncol Biol Phys. 2025 Feb 8:S0360-3016(25)00093.
    PubMed     Abstract available
    
    
    
22. MA N, Ming X, Chen J, Jiang GL, et al
    Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
    Int J Radiat Oncol Biol Phys. 2025 Feb 5:S0360-3016(25)00094.
    PubMed     Abstract available
    
    
    
23. SHIN YS, Yun JK, Jung J, Park JH, et al
    Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:432-441.
    PubMed     Abstract available
    
    
    January 2025
24. LATIFI A, Roumeliotis M, Quirk S, Gardner UG, et al
    Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot.
    Int J Radiat Oncol Biol Phys. 2025 Jan 25:S0360-3016(25)00078.
    PubMed     Abstract available
    
    
    
25. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    PubMed     Abstract available
    
    
    
26. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    PubMed     Abstract available
    
    
    
27. WANG E, Abdallah H, Snir J, Chong J, et al
    Predicting the 3-Dimensional Dose Distribution of Multilesion Lung Stereotactic Ablative Radiation Therapy With Generative Adversarial Networks.
    Int J Radiat Oncol Biol Phys. 2025;121:250-260.
    PubMed     Abstract available
    
    
    
28. WANG Y, Dong X, Yan S, Liu B, et al
    Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer: A Propensity Score Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:45-55.
    PubMed     Abstract available
    
    
    December 2024
29. BARRETT S, Zahid MU, Enderling H, Marignol L, et al
    Predicting Individual Tumor Response Dynamics in Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy: A Mathematical Modelling Study.
    Int J Radiat Oncol Biol Phys. 2024 Dec 3:S0360-3016(24)03563.
    PubMed     Abstract available
    
    
    November 2024
30. KEANE FK, Yeap BY, Khandekar MJ, Lin JJ, et al
    Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors.
    Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515.
    PubMed     Abstract available
    
    
    
31. DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al
    Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
    PubMed     Abstract available
    
    
    
32. ZHAO X, Huang S, Lin H, Choi JI, et al
    A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil Beam Scanning FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;120:1181-1191.
    PubMed     Abstract available
    
    
    
33. SIMONE CB 2ND
    Enhancing Outcomes in Locally Advanced Non-Small Cell Lung Cancer Through Stereotactic Dose Escalation.
    Int J Radiat Oncol Biol Phys. 2024;120:695-697.
    PubMed    
    
    
    
34. SAMSON P, Harris JP
    Here Comes the Sun: Continuing to Refine the Treatment of Ultracentral Non-Small Cell Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:678-680.
    PubMed    
    
    
    
35. ZHANG S, Simard M, Lapointe A, Filion E, et al
    Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived From Dual-Energy Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;120:894-903.
    PubMed     Abstract available
    
    
    October 2024
36. WEISMAN M, Durm G, Shields MD, Hanna NH, et al
    Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NSCLC): Big Ten
    Int J Radiat Oncol Biol Phys. 2024 Oct 25:S0360-3016(24)03450.
    PubMed     Abstract available
    
    
    
37. SADDOUGHI SA, Kern R
    Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can All Have a Piece of the Pie.
    Int J Radiat Oncol Biol Phys. 2024;120:357-358.
    PubMed    
    
    
    
38. MCCALL NS, Higgins KA
    Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:343-344.
    PubMed    
    
    
    
39. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
    Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:309-314.
    PubMed    
    
    
    
40. LI GJ, Tan H, Nusrat H, Chang J, et al
    Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
    Int J Radiat Oncol Biol Phys. 2024;120:359-369.
    PubMed     Abstract available
    
    
    
41. KAMTAM DN, Binkley MS, Kapula N, Sadeghi C, et al
    First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
    Int J Radiat Oncol Biol Phys. 2024;120:345-356.
    PubMed     Abstract available
    
    
    September 2024
42. IGARASHI A, Onishi H, Shioyama Y, Matsumoto Y, et al
    Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan.
    Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174.
    PubMed     Abstract available
    
    
    
43. GENSHEIMER MF, Kotha NV, Vitzthum LK, Chin AL, et al
    A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410.
    PubMed     Abstract available
    
    
    
44. MACMANUS MP, Prins E, Xie J, Akhurst T, et al
    Dose-response relationships between radiation exposure, bone marrow function as measured by (18)F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 2:S0360-3016(24)03290.
    PubMed     Abstract available
    
    
    
45. RANKINE LJ, Lu J, Wang Z, Kelsey CR, et al
    Quantifying Regional Radiation-Induced Lung Injury in Patients Using Hyperpolarized (129)Xe Gas Exchange Magnetic Resonance Imaging.
    Int J Radiat Oncol Biol Phys. 2024;120:216-228.
    PubMed     Abstract available
    
    
    August 2024
46. ZHANG Y, Iyengar P, Montalvo S, Westover KD, et al
    Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03177.
    PubMed     Abstract available
    
    
    
47. TAN VS, Correa RJM, Nguyen TK, Louie AV, et al
    Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173.
    PubMed     Abstract available
    
    
    
48. GRONBERG BH
    Are We Finally Ready to Implement Twice-Daily Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2024;119:1391-1392.
    PubMed    
    
    
    
49. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
    Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
    PubMed     Abstract available
    
    
    
50. PORTIER L, Daira P, Fourmaux B, Heinrich S, et al
    Differential Remodeling of the Oxylipin Pool After FLASH Versus Conventional Dose-Rate Irradiation In Vitro and In Vivo.
    Int J Radiat Oncol Biol Phys. 2024;119:1481-1492.
    PubMed     Abstract available
    
    
    July 2024
51. HARRIS JP, Samson P, Owen D, Siva S, et al
    Adapt or Perish: Adaptive RT for NSCLC.
    Int J Radiat Oncol Biol Phys. 2024;119:1047-1051.
    PubMed    
    
    
    
52. LIU W, Feng H, Taylor PA, Kang M, et al
    NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies.
    Int J Radiat Oncol Biol Phys. 2024;119:1208-1221.
    PubMed     Abstract available
    
    
    
53. EDWARDS DM, Schonewolf CA, Rice JD, Schipper M, et al
    Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749.
    PubMed     Abstract available
    
    
    
54. 
    Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J Radiat Oncol Biol Phys 2020;108(3):758-769.
    Int J Radiat Oncol Biol Phys. 2024;119:1030-1031.
    PubMed    
    
    
    
55. 
    Erratum to: Simone CB 2nd, Serebrenik AA, Gore EM, et al. Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Ph
    Int J Radiat Oncol Biol Phys. 2024;119:1029.
    PubMed    
    
    
    
56. HARRISON N, Kang M, Liu R, Charyyev S, et al
    A Novel Inverse Algorithm To Solve the Integrated Optimization of Dose, Dose Rate, and Linear Energy Transfer of Proton FLASH Therapy With Sparse Filters.
    Int J Radiat Oncol Biol Phys. 2024;119:957-967.
    PubMed     Abstract available
    
    
    June 2024
57. NI J, Chen H, Yu L, Guo T, et al
    Predicting regional recurrence and prognosis in stereotactic body radiotherapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00743.
    PubMed     Abstract available
    
    
    
58. CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al
    Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:640-654.
    PubMed     Abstract available
    
    
    May 2024
59. LEE HI, Choi EK, Kim SS, Shin YS, et al
    Local Ablative Therapy Combined with Pembrolizumab in Patients with Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis.
    Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00674.
    PubMed     Abstract available
    
    
    April 2024
60. MIDRONI J, Salunkhe R, Liu Z, Chow R, et al
    Incorporating functional lung imaging (FLI) into radiation therapy planning in patients with lung cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00481.
    PubMed     Abstract available
    
    
    
61. ZHANG Q, Fan S, Xu X, Du S, et al
    Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy with Helical TomoTherapy versus Conventional Radiotherapy in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicentre, Randomized
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00450.
    PubMed     Abstract available
    
    
    
62. MEREDITH EG, Filion E, Faria S, Kundapur V, et al
    Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00480.
    PubMed     Abstract available
    
    
    
63. LOMBARDO J, Castillo E, Castillo R, Miller R, et al
    Prospective trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00476.
    PubMed     Abstract available
    
    
    
64. LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al
    Evaluation of radiotherapy treatment plans in a randomized phase II trial comparing two schedules of twice-daily thoracic radiotherapy in limited stage small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00475.
    PubMed     Abstract available
    
    
    
65. VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al
    BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1172-1180.
    PubMed     Abstract available
    
    
    
66. HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al
    Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors influencing survival benefit in combination trials.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449.
    PubMed     Abstract available
    
    
    March 2024
67. KIM KH, Kang N, Song SY, Kim HJ, et al
    Safety and efficacy of HL301 in radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving curative concurrent chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled, phase IIa clinical trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447.
    PubMed     Abstract available
    
    
    
68. FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al
    SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;118:971-978.
    PubMed     Abstract available
    
    
    
69. LUCIA F, Bourhis D, Pinot F, Hamya M, et al
    Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;118:952-962.
    PubMed     Abstract available
    
    
    
70. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
    Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
    Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
    PubMed     Abstract available
    
    
    
71. WALLS GM, Mistry H, Barlesi F, Bezjak A, et al
    Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer: a brief report from the CONVERT trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 11:S0360-3016(24)00382.
    PubMed     Abstract available
    
    
    
72. YAN W, Ren Z, Chen X, Zhang R, et al
    Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiotherapy and surgery for early-stage non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356.
    PubMed     Abstract available
    
    
    
73. SHUJA M, Owen D
    What if Perioperative Therapy for Non-Small Cell Lung Cancer Renders Someone Inoperable?
    Int J Radiat Oncol Biol Phys. 2024;118:587.
    PubMed    
    
    
    
74. FARLEY A, Nelson B
    Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung Cancer: Queen's Gambit or CheckMate?
    Int J Radiat Oncol Biol Phys. 2024;118:585-586.
    PubMed    
    
    
    February 2024
75. BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
    A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
    PubMed     Abstract available
    
    
    
76. WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
    A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
    PubMed     Abstract available
    
    
    
77. HAN C, Qiu J, Bai L, Liu T, et al
    Pneumonitis risk after chemoradiotherapy with and without immunotherapy in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024 Feb 13:S0360-3016(24)00298.
    PubMed     Abstract available
    
    
    
78. KIM H, Lee E, Cho H, Kim E, et al
    Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity.
    Int J Radiat Oncol Biol Phys. 2024;118:498-511.
    PubMed     Abstract available
    
    
    January 2024
79. WANG J, Liu Y, Wu D, Tian C, et al
    OTUB1 targets CHK1 for deubiquitinating and stabilizing to facilitate lung cancer progression and radioresistance.
    Int J Radiat Oncol Biol Phys. 2024 Jan 22:S0360-3016(24)00246.
    PubMed     Abstract available
    
    
    
80. TRAN PT, Mouw KW
    SABR Today . . . and Tomorrow?
    Int J Radiat Oncol Biol Phys. 2024;118:11.
    PubMed    
    
    
    
81. WRIGHT JL, Bazan JG
    Time to Reconsider the Role of Diagnostic Chest Computed Tomography in Early-Stage Breast Cancer?
    Int J Radiat Oncol Biol Phys. 2024;118:104-106.
    PubMed    
    
    
    
82. CHEN Y, Pahlavian SH, Jacobs P, Neupane T, et al
    Systematic Evaluation of the Impact of Lung Segmentation Methods on 4-Dimensional Computed Tomography Ventilation Imaging Using a Large Patient Database.
    Int J Radiat Oncol Biol Phys. 2024;118:242-252.
    PubMed     Abstract available
    
    
    December 2023
83. BARTOLOMEO V, Cortiula F, Hendriks LEL, De Ruysscher D, et al
    A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Dec 27:S0360-3016(23)08126.
    PubMed    
    
    
    
84. RIMNER A, Gelblum DY, Wu AJ, Shepherd AF, et al
    Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer - A Phase I Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08252.
    PubMed     Abstract available
    
    
    
85. RAN X, Wu BX, Shi M, Song L, et al
    CRISPR screen of druggable targets in small cell lung cancer identified ATM inhibitor (AZD1390) as a radiosensitizer.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08245.
    PubMed     Abstract available
    
    
    
86. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    PubMed     Abstract available
    
    
    
87. BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al
    Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase Ib Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166.
    PubMed     Abstract available
    
    
    
88. DUDAS D, Saghad PG, Dilling TJ, Perez BA, et al
    Deep Learning-Guided Dosimetry for Mitigating Local Failure of Non-Small Cell Lung Cancer Patients Receiving SBRT.
    Int J Radiat Oncol Biol Phys. 2023 Dec 4:S0360-3016(23)08185.
    PubMed     Abstract available
    
    
    
89. SAFAVI AH, Palma DA, Giuliani ME
    Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?
    Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
    PubMed    
    
    
    
90. SIVA S, Staehler M
    The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
    Int J Radiat Oncol Biol Phys. 2023;117:1047.
    PubMed    
    
    
    
91. AHN J, Yeghiaian-Alvandi R, Hegi-Johnson F, Browne LH, et al
    SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life.
    Int J Radiat Oncol Biol Phys. 2023;117:1213-1221.
    PubMed     Abstract available
    
    
    
92. LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al
    Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
    PubMed     Abstract available
    
    
    
93. LEE SH, Geng H, Arnold J, Caruana R, et al
    Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
    Int J Radiat Oncol Biol Phys. 2023;117:1270-1286.
    PubMed     Abstract available
    
    
    November 2023
94. MA J, Li Y, Yu H, Zhang J, et al
    The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Non-Small Cell Lung Cancer Patients Receiving Lung Radiotherapy and Immunotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08165.
    PubMed     Abstract available
    
    
    
95. VALDES G, Scholey J, Nano T, Gennatas ED, et al
    Predicting the impact of proton beam therapy technology on pulmonary toxicities for locally advanced lung cancer patients enrolled on the Proton Collaborative Group prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2023 Nov 22:S0360-3016(23)08154.
    PubMed     Abstract available
    
    
    
96. RAMESH S, Cifci A, Javeri S, Minne R, et al
    MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08139.
    PubMed     Abstract available
    
    
    
97. RITTER AR, Miller ED
    No Regrets About SABR for NETs.
    Int J Radiat Oncol Biol Phys. 2023;117:786.
    PubMed    
    
    
    
98. OMIDI A, Weiss E, Rosu-Bubulac M, Thomas G, et al
    Quantitative analysis of radiotherapy-induced cardiac and aortic sequelae in lung cancer patients via magnetic resonance imaging: A pilot study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08045.
    PubMed     Abstract available
    
    
    
99. KUIPERS ME, van Doorn-Wink KCJ, Hiemstra PS, Slats AM, et al
    Predicting radiation-induced lung injury in lung cancer patients - challenges and opportunities: Predicting radiation-induced lung injury.
    Int J Radiat Oncol Biol Phys. 2023 Nov 2:S0360-3016(23)08049.
    PubMed     Abstract available
    
    
    
100. HEGI-JOHNSON F, Rudd SE, Wichmann CW, Akhurst T, et al
     PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
     Int J Radiat Oncol Biol Phys. 2023;117:675-682.
     PubMed    
     
     
     October 2023
101. GAUDREAULT M, Bucknell N, Woon B, Kron T, et al
     Dose-response relationship between radiotherapy and loss of lung perfusion comparing positron emission tomography and dual-energy computed tomography in non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08047.
     PubMed     Abstract available
     
     
     
102. FRIEDES C, Iocolano M, Lee SH, Li B, et al
     Patterns of Failure, Low Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors: Patterns of Failure for after PACIFIC.
     Int J Radiat Oncol Biol Phys. 2023 Oct 20:S0360-3016(23)08010.
     PubMed     Abstract available
     
     
     
103. EDWARDS DM, Sankar K, Alseri A, Jiang R, et al
     Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971.
     PubMed     Abstract available
     
     
     September 2023
104. LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al
     Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929.
     PubMed     Abstract available
     
     
     
105. MENG Y, Sun H, Wang S, Yang H, et al
     Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
     Int J Radiat Oncol Biol Phys. 2023 Sep 14:S0360-3016(23)07917.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.